简体中文
|
繁體中文
|
English
Home
News
Events
Media Services
About Us
About Interfax
Contact Us
Recent Releases
2026-10-26 15:32
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
2026-10-26 15:30
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer
2026-10-26 14:49
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project
2026-10-26 14:04
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.
2026-10-26 13:50
Energy Impact Partners Deepens Partnership with Singapore Economic Development Board to Advance Energy Innovation & Decarbonisation
2026-10-26 12:04
Mundipharma Announces Further Phase III ReSPECT Results Presented as a Late-Breaking Oral Presentation at IDWeek 2026
2026-10-26 11:54
Ruler of Ras Al Khaimah Inaugurates the First Ras Al Khaimah’s Business Consultancy in China, Strengthening Ties With Guangdong
2026-10-26 11:20
Tigo Energy Improves Installer Choice via Fronius Compatibility with TS4 Product Line
2026-10-26 11:17
Saudi Maritime & Logistics Congress Highlights Maritime Sector Integration and Opportunities for Trade and Investment Growth in the Kingdom
2026-10-26 10:20
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study
2026-10-23 15:20
SBC Medical Initiates Development of a DNA Methylation Test to Estimate Biological Age
2026-10-23 15:14
Ministerial Roundtable Discusses Mobilising Green Investments for a Resilient and Inclusive Global Economy
2026-10-23 15:11
Megaport Expands AWS Connectivity With AWS Interconnect to Simplify How Customers Connect Their Infrastructure
2026-10-23 14:48
AMWC Dubai 2026: Galderma Reinforces Its Injectable Aesthetics Leadership
2026-10-23 14:39
Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License
More releases »
Events